Home000520 • KRX
add
Samil Pharmaceutical Co Ltd
Previous close
₩10,440.00
Year range
₩9,120.00 - ₩15,400.00
Market cap
226.46B KRW
Avg Volume
336.78K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 51.18B | -4.02% |
Operating expense | 23.65B | 19.93% |
Net income | -7.93B | -1,072.05% |
Net profit margin | -15.49 | -1,119.69% |
Earnings per share | — | — |
EBITDA | -1.91B | -270.56% |
Effective tax rate | -2.92% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.49B | 62.51% |
Total assets | 377.44B | -1.77% |
Total liabilities | 234.35B | 11.82% |
Total equity | 143.09B | — |
Shares outstanding | 21.25M | — |
Price to book | 1.55 | — |
Return on assets | -3.43% | — |
Return on capital | -4.19% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.93B | -1,072.05% |
Cash from operations | 2.79B | 344.74% |
Cash from investing | -1.08B | 54.60% |
Cash from financing | 2.15B | -43.29% |
Net change in cash | 3.84B | 93.43% |
Free cash flow | 1.03B | 1,650.43% |
About
Founded
1947
Website
Employees
583